Not everyone agrees that another round of patent reform is necessary at this time. Doubters believe that the Innovation Act, H.R. 9 in its current form, will
Not everyone agrees that another round of patent reform is necessary at this time. Doubters believe that the Innovation Act, H.R. 9 in its current form, will
The comment that follows is from Life360 CEO Chris Hulls in response to the 2/9/15 IP CloseUp post, “Family App Developer Says it’s the Victim
When it comes to invention rights (patents) it is often difficult to determine who is a victim and who is merely promoting its agenda. Life360,
More than half of Google and Microsoft’s 2014 US patent grants were in methods-related classes. IBM and Apple also were active filers in these areas.
Size helped in 2014 when it came to public IP licensing company stock performance, but it did not assure success. As a group, the twelve
More than one-third of the IP CloseUp® 30 public patent licensing companies (or PIPCOs) are currently selling for less than or about $1 per share —
The stock market continues to defy expectations. Even more surprising, a few PIPCOs have dramatically outperformed it. Smaller cap patent stocks have not fared so
The rights to an expensive drug treatment owned by the Cystic Fibrosis Foundation has helped it to reap a financial windfall but is not without
As businesses adjust to new judicial and legislative requirements public patent licensing companies will have to work harder and think smarter to compete against the
With three recent Markman hearings and more than $100M in cash UPIP trading currently at $1.46 could be a good buy for those with patience
Expect a transaction to yield some clues about which smart phone-related patents are interesting, what they are worth and to whom. Struggling South Korean handset
What’s to be learned from PwC’s 2014 Patent Litigation Survey that we don’t already know? Patent suits are at an all-time high, with almost 6,500